About Aarvik Therapeutics
Aarvik Therapeutics is a private company based in Hayward, California, incorporated in 2020 in Delaware. It has reported $9,498,333 raised in two offerings on Form D since September 2021. Its chief executive is Jagath Reddy Junutula.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 2024 | Dec 11, 2024 | $1,165,000of $15.0M target | 5 | $233K | EquityRule 506(b) | Form D ↗ |
| Aug 18, 2021 | Sep 2, 2021 | $8,333,333fully sold | 112 | $74,405 | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $9,498,333 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Aarvik Therapeutics's Form D filed Dec 11, 2024.
SS
Sachdev Sidhu
Director
AJ
Anula Jayasuriya
Director
JJ
Jagath Reddy Junutula
Chief Executive Officer and director
RR
Ram Reddy
Director
RS
Richard Scheller
Director